HSPG2 knockdown or Ara‐C intervention reduced HSPG2 level and led to BM EPC dysfunction, HSPG2 treatment could repair these damages and restored the BM EPC function of AML‐CR patients. This evidence concerns the gene HSPG2 and acute myeloid leukemia.